| # | Drug | Count |
|---|---|---|
| 0 | RALTEGRAVIR | 10 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE | 9 |
| 2 | ABACAVIR SULFATE | 8 |
| 3 | MARAVIROC | 8 |
| 4 | ABACAVIR | 7 |
| 5 | LAMIVUDINE | 7 |
| 6 | LAMIVUDINE ORAL | 7 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 7 |
| 8 | ZIDOVUDINE | 7 |
| 9 | ENTECAVIR | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 8 | 0.0035 |
| 1 | RALTEGRAVIR | 10 | 0.0019 |
| 2 | ABACAVIR SULFATE | 8 | 0.0008 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 7 | 0.0008 |
| 4 | ETRAVIRINE | 3 | 0.0007 |
| 5 | ZIDOVUDINE | 7 | 0.0007 |
| 6 | ENTECAVIR | 6 | 0.0005 |
| 7 | EFAVIRENZ | 5 | 0.0005 |
| 8 | DARUNAVIR | 5 | 0.0003 |
| 9 | DARUNAVIR 600 MG | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 8 | 0.0035 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0002 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0002 |
| 4 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 8 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |